Global Health Q2 Results 2024: Profit Rises by 4.54% YOY, Profit at ₹130.84 Crore and Revenue at ₹956.55 Crore
Global Health Q2 Results 2024 on 17 Nov, 2024: Revenue increased by 13.34% YoY & profit increased by 4.54% YoY, profit at ₹130.84 crore and revenue at ₹956.55 crore.
Global Health Q2 Results 2024:Global Health declared their Q2 results on 14 Nov, 2024, reporting a notable increase in both revenue and profit. The company's revenue surged by 13.34% year-over-year, reaching ₹956.55 crore, while profit rose by 4.54% to ₹130.84 crore.
In comparison to the previous quarter, the company's financial performance showed significant improvement with revenue growing by 11.09% and profit increasing by 23.11%. This upward trend indicates a strong operational performance in the healthcare sector.
However, the Selling, General & Administrative expenses saw a rise of 3.71% quarter-over-quarter, reflecting increased operational costs, which were also up by 13.49% year-over-year. This increase in expenses could impact future profit margins if not managed effectively.
On a positive note, the operating income demonstrated remarkable growth, up by 28.03% quarter-over-quarter and 5.25% year-over-year, indicating robust operational efficiency and productivity improvements.
The Earnings Per Share (EPS) for Q2 was reported at ₹5.03, marking an increase of 8.02% year-over-year. This positive EPS growth is a strong indicator of the company's profitability and financial health.
Despite a challenging market environment, Global Health has delivered a -1.21% return in the last week and a -23.15% return over the past six months. However, the company has shown resilience with an 11.76% year-to-date return, which may attract potential investors.
As of the latest report, Global Health holds a market capitalization of ₹28,786.94 crore, with a 52-week high of ₹1,513.9 and a low of ₹881.3. This market performance underscores the company's stability and growth potential.
Among analysts covering Global Health, the consensus recommendation as of 17 Nov, 2024, suggests a Buy, with 2 analysts giving a Sell rating, 3 a Hold rating, 1 a Buy rating, and 3 recommending a Strong Buy. This mixed sentiment reflects varied expectations about the company's future performance.
Global Health Financials
| Period | Q2 | Q1 | Q-o-Q Growth | Q2 | Y-o-Y Growth |
|---|---|---|---|---|---|
| Total Revenue | 956.55 | 861.08 | +11.09% | 843.94 | +13.34% |
| Selling/ General/ Admin Expenses Total | 336.62 | 324.57 | +3.71% | 296.61 | +13.49% |
| Depreciation/ Amortization | 49.43 | 46.62 | +6.03% | 42.91 | +15.2% |
| Total Operating Expense | 777.7 | 721.37 | +7.81% | 674 | +15.39% |
| Operating Income | 178.86 | 139.7 | +28.03% | 169.94 | +5.25% |
| Net Income Before Taxes | 181.1 | 143.65 | +26.07% | 170.6 | +6.15% |
| Net Income | 130.84 | 106.29 | +23.11% | 125.16 | +4.54% |
| Diluted Normalized EPS | 5.03 | 3.96 | +27.12% | 4.66 | +8.02% |
Disclaimer: This is an AI-generated live blog and has not been edited by LiveMint staff.
Catch all the Business News , Corporate news , Breaking News Events and Latest News Updates on Live Mint. Download The Mint News App to get Daily Market Updates.